PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportshemophilia b
MeSH D002836 - hemophilia b
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006474:Hemorrhagic disorders
1 Company
1 Drug
$
Success rate
D040181:X-linked genetic diseases
0 Companies
0 Drugs
Success rate
D025861:Inherited blood coagulation disorders
27 Companies
2 Drugs
$
Success rate
D020147:Coagulation protein disorders
0 Companies
0 Drugs
Success rate
D002836: 
Hemophilia b
7 Companies
8 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Novo NordiskEptacog alfa (activated) NovoSeven  1996-02-23   
Nonacog beta pegol Refixia  2017-06-02   
Orphan MedicalEftrenonacog alfa Alprolix  2016-05-12   
PfizerNonacog alfa BeneFIX  1997-08-27 $424 M Y2023 
SanquinHuman coagulation factor ix Nonafact  2001-07-03   
Clinical Trials
Historical Success Rate
Phase 1
83%
10/12
Phase 2
69%
9/13
Phase 3
54%
14/26
Approved: 5Overall Success rate: 31%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Baxalta
Ademetionine,
Coagulation factor viia recombinant human,
Coagulation factor ix human,
Feiba,
Octaplex,
Rfviia,
Articular,
Bolus,
Demand,
Pcc
CSL Behring
Albumin,
Antithrombin iii,
Serine,
Alpha1-proteinase inhibitor,
Bevifimod,
Demcizumab,
Coagulation factor viia recombinant human,
Coagulation factor ix human,
Endocrine,
Rfviia,
Articular,
Demand,
Pcc
Novo Nordisk
Nonacog beta pegol,
Eptacog alfa (activated),
Concizumab,
Ademetionine,
Aspartame,
Demcizumab,
EPTACOG ALFA PEGOL (ACTIVATED),
Coagulation factor viia recombinant human,
Coagulation factor ix human,
Feiba,
Rfviia,
Articular,
Arm1,
Arm2,
Bolus,
Demand,
Pcc
Orphan Medical
Eftrenonacog alfa,
Aspartame,
Bevifimod,
Coagulation factor ix human,
Rfviiifc,
Articular,
Demand,
Pcc
Pfizer
Nonacog alfa,
Fidanacogene elaparvovec,
Concizumab,
Tifacogin,
Befovacimab,
Bevifimod,
Demcizumab,
Edetic acid,
Coagulation factor ix human,
Bay-1093884,
Ph3,
Demand,
Pcc
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use